287 related articles for article (PubMed ID: 26155428)
1. The tumoral and stromal immune microenvironment in malignant pleural mesothelioma: A comprehensive analysis reveals prognostic immune markers.
Ujiie H; Kadota K; Nitadori JI; Aerts JG; Woo KM; Sima CS; Travis WD; Jones DR; Krug LM; Adusumilli PS
Oncoimmunology; 2015 Jun; 4(6):e1009285. PubMed ID: 26155428
[TBL] [Abstract][Full Text] [Related]
2. Tumor-Infiltrating CD20
Suárez-Sánchez FJ; Lequerica-Fernández P; Rodrigo JP; Hermida-Prado F; Suárez-Canto J; Rodríguez-Santamarta T; Domínguez-Iglesias F; García-Pedrero JM; de Vicente JC
Cancers (Basel); 2021 Jan; 13(3):. PubMed ID: 33494389
[TBL] [Abstract][Full Text] [Related]
3. CD70 expression correlates with a worse prognosis in malignant pleural mesothelioma patients via immune evasion and enhanced invasiveness.
Inaguma S; Lasota J; Czapiewski P; Langfort R; Rys J; Szpor J; Waloszczyk P; Okoń K; Biernat W; Schrump DS; Hassan R; Kasai K; Miettinen M; Ikeda H
J Pathol; 2020 Feb; 250(2):205-216. PubMed ID: 31639216
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the immune microenvironment in malignant pleural mesothelioma reveals prognostic subgroups of patients.
Fusco N; Vaira V; Righi I; Sajjadi E; Venetis K; Lopez G; Cattaneo M; Castellani M; Rosso L; Nosotti M; Clerici M; Ferrero S
Lung Cancer; 2020 Dec; 150():53-61. PubMed ID: 33065463
[TBL] [Abstract][Full Text] [Related]
5. Ratio of intratumoral macrophage phenotypes is a prognostic factor in epithelioid malignant pleural mesothelioma.
Cornelissen R; Lievense LA; Maat AP; Hendriks RW; Hoogsteden HC; Bogers AJ; Hegmans JP; Aerts JG
PLoS One; 2014; 9(9):e106742. PubMed ID: 25192022
[TBL] [Abstract][Full Text] [Related]
6. High BIN1 expression has a favorable prognosis in malignant pleural mesothelioma and is associated with tumor infiltrating lymphocytes.
Ahmadzada T; Lee K; Clarke C; Cooper WA; Linton A; McCaughan B; Asher R; Clarke S; Reid G; Kao S
Lung Cancer; 2019 Apr; 130():35-41. PubMed ID: 30885349
[TBL] [Abstract][Full Text] [Related]
7. Malignant pleural mesothelioma immune microenvironment and checkpoint expression: correlation with clinical-pathological features and intratumor heterogeneity over time.
Pasello G; Zago G; Lunardi F; Urso L; Kern I; Vlacic G; Grosso F; Mencoboni M; Ceresoli GL; Schiavon M; Pezzuto F; Pavan A; Vuljan SE; Del Bianco P; Conte P; Rea F; Calabrese F
Ann Oncol; 2018 May; 29(5):1258-1265. PubMed ID: 29514216
[TBL] [Abstract][Full Text] [Related]
8. Potential Diagnostic and Prognostic Role of Microenvironment in Malignant Pleural Mesothelioma.
Salaroglio IC; Kopecka J; Napoli F; Pradotto M; Maletta F; Costardi L; Gagliasso M; Milosevic V; Ananthanarayanan P; Bironzo P; Tabbò F; Cartia CF; Passone E; Comunanza V; Ardissone F; Ruffini E; Bussolino F; Righi L; Novello S; Di Maio M; Papotti M; Scagliotti GV; Riganti C
J Thorac Oncol; 2019 Aug; 14(8):1458-1471. PubMed ID: 31078776
[TBL] [Abstract][Full Text] [Related]
9. Tumor microenvironment in triple-negative breast cancer: the correlation of tumor-associated macrophages and tumor-infiltrating lymphocytes.
Kuroda H; Jamiyan T; Yamaguchi R; Kakumoto A; Abe A; Harada O; Masunaga A
Clin Transl Oncol; 2021 Dec; 23(12):2513-2525. PubMed ID: 34089486
[TBL] [Abstract][Full Text] [Related]
10. Immune-cell infiltration in high-grade soft tissue sarcomas; prognostic implications of tumor-associated macrophages and B-cells.
Nyström H; Jönsson M; Nilbert M; Carneiro A
Acta Oncol; 2023 Jan; 62(1):33-39. PubMed ID: 36786033
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneity in Immune Cell Content in Malignant Pleural Mesothelioma.
Minnema-Luiting J; Vroman H; Aerts J; Cornelissen R
Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29601534
[TBL] [Abstract][Full Text] [Related]
12. Tumor-infiltrating lymphocytes are functionally inactivated by CD90+ stromal cells and reactivated by combined Ibrutinib and Rapamycin in human pleural mesothelioma.
Yang H; Berezowska S; Dorn P; Zens P; Chen P; Peng RW; Marti TM; Kocher GJ; Schmid RA; Hall SRR
Theranostics; 2022; 12(1):167-185. PubMed ID: 34987640
[No Abstract] [Full Text] [Related]
13. Immune cell analyses of the tumor microenvironment in prostate cancer highlight infiltrating regulatory T cells and macrophages as adverse prognostic factors.
Andersen LB; Nørgaard M; Rasmussen M; Fredsøe J; Borre M; Ulhøi BP; Sørensen KD
J Pathol; 2021 Oct; 255(2):155-165. PubMed ID: 34255349
[TBL] [Abstract][Full Text] [Related]
14. The Immune Microenvironment, Genome-wide Copy Number Aberrations, and Survival in Mesothelioma.
Thapa B; Salcedo A; Lin X; Walkiewicz M; Murone C; Ameratunga M; Asadi K; Deb S; Barnett SA; Knight S; Mitchell P; Watkins DN; Boutros PC; John T
J Thorac Oncol; 2017 May; 12(5):850-859. PubMed ID: 28257959
[TBL] [Abstract][Full Text] [Related]
15. P14/ARF-Positive Malignant Pleural Mesothelioma: A Phenotype With Distinct Immune Microenvironment.
Pezzuto F; Lunardi F; Vedovelli L; Fortarezza F; Urso L; Grosso F; Ceresoli GL; Kern I; Vlacic G; Faccioli E; Schiavon M; Gregori D; Rea F; Pasello G; Calabrese F
Front Oncol; 2021; 11():653497. PubMed ID: 33828993
[TBL] [Abstract][Full Text] [Related]
16. Prognostic implications of preoperative systemic inflammatory markers in oral squamous cell carcinoma, and correlations with the local immune tumor microenvironment.
Ruiz-Ranz M; Lequerica-Fernández P; Rodríguez-Santamarta T; Suárez-Sánchez FJ; López-Pintor RM; García-Pedrero JM; de Vicente JC
Front Immunol; 2022; 13():941351. PubMed ID: 35958590
[TBL] [Abstract][Full Text] [Related]
17. Prognostic influence of tumor microenvironment after hypofractionated radiation and surgery for mesothelioma.
de Perrot M; Wu L; Cabanero M; Perentes JY; McKee TD; Donahoe L; Bradbury P; Kohno M; Chan ML; Murakami J; Keshavjee S; Tsao MS; Cho BCJ
J Thorac Cardiovasc Surg; 2020 May; 159(5):2082-2091.e1. PubMed ID: 31866087
[TBL] [Abstract][Full Text] [Related]
18. Mesothelin expression remodeled the immune-matrix tumor microenvironment predicting the risk of death in patients with malignant pleural mesothelioma.
Qualiotto AN; Baldavira CM; Balancin M; Ab'Saber A; Takagaki T; Capelozzi VL
Front Immunol; 2023; 14():1268927. PubMed ID: 37901248
[TBL] [Abstract][Full Text] [Related]
19. Impact of tumor-infiltrating T cells on survival in patients with malignant pleural mesothelioma.
Anraku M; Cunningham KS; Yun Z; Tsao MS; Zhang L; Keshavjee S; Johnston MR; de Perrot M
J Thorac Cardiovasc Surg; 2008 Apr; 135(4):823-9. PubMed ID: 18374762
[TBL] [Abstract][Full Text] [Related]
20. Tumor-associated CD163
Yoshida C; Kadota K; Yamada K; Fujimoto S; Ibuki E; Ishikawa R; Haba R; Yokomise H
Lung Cancer; 2022 May; 167():34-40. PubMed ID: 35395482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]